Rhododendron

Rhododendron: A Comprehensive Reference on Botanical Identity, Traditional Use, Phytochemistry, Pharmacology, and Safety

1. Identity and Botanical Classification

Genus and family: Rhododendron L. is the type genus of the family Ericaceae (heath family). Rhododendron, the largest genus of Ericaceae, consists of approximately 1,000 species that are widely distributed in Europe, Asia, and North America, but mainly exist in Asia. Comprising eight subgenera with more than 960 species, most are distributed in Southeast Asia and the Himalayan region of the Northern Hemisphere, while others grow in Europe, North America, and northeastern Australia.

Botanical description: Rhododendron is a flowering, green, and shrub-like plant with simple, alternate, entire leaves; funnel-shaped flowers in terminal umbel-like clusters or solitary and of various colors; and fruits are capsules with many seeds. Some species grow as low ground covers while others reach the stature of small trees.

Species diversity and geographic centers: Worldwide, around 1,200 species of Rhododendron have been estimated, among which China has the highest number, with 571 species, of which 409 are endemic. In India, there are about 80 species, 10 subspecies, and 14 varieties. Existing records indicate that 98% of the Indian species are found in the Himalayan region, and 72% are found in Sikkim.

Etymological note: The word Rhododendron is derived from the Greek rhodo, meaning rose, and dendron, meaning tree.

Taxonomic notes: The genus formerly subsumed several closely related genera. For instance, Rhodora (Linnaeus, 1763) for Rhododendron canadense, Vireya (Blume, 1826), and Hymenanthes (Blume, 1826) were originally separate, and finally in 1836, Azalea was incorporated into Rhododendron, with the genus divided into eight sections. Of particular relevance to herbalists and researchers, the species formerly known as Ledum palustre is now classified as Rhododendron tomentosum Harmaja (previously: Ledum palustre), a fragrant evergreen shrub found in peaty soils in northern Europe, Asia, and North America, commonly referred to as wild rosemary, marsh tea, marsh rosemary, or northern Labrador tea.

Medically Significant Species

• Rhododendron dauricum L. — a traditional herb mainly distributed in northeast China, Mongolia, the Korean Peninsula, and the Russian Far East, known in Chinese medicine as "Man Shan Hong."
• Rhododendron arboreum Sm. — an angiosperm bearing eye-catching bright red flowers, belonging to family Ericaceae, and the national flower of Nepal.
• Rhododendron molle G. Don — known in China as "NaoYangHua," it has the longest medicinal use history and has been documented in the Chinese Pharmacopoeia 2020 Edition for the treatment of rheumatic arthralgia and pain.
• Rhododendron tomentosum Harmaja (syn. Ledum palustre) — a northern European and Asian species used widely in folk medicine.
• Rhododendron ponticum L. — a European and West Asian species associated notably with the production of grayanotoxin-containing honey.
• Rhododendron ferrugineum L. — alpine European species studied for hepatoprotective properties.
• Rhododendron oldhamii Maxim. — a Taiwanese species investigated for anti-hyperuricemic effects.

Common Forms and Preparations

Flowers of this plant are traditionally utilized by people residing in mountainous regions to make pickle, juice, jam, syrup, honey, squash, etc., and to treat various ailments like diarrhea, headache, inflammation, and bacterial and fungal infections. In more formal medical contexts, the essential oil Manshanhongyou (Oleum Rhododendri daurici), obtained by steam distillation of the dry leaves of R. dauricum, and its galenic preparation Manshanhongyou Jiaowan (Capsulae Olei Rhododendri daurici), are officially listed in the Chinese Pharmacopoeia. R. dauricum foliage (RDF) is frequently utilized as a potent ingredient in Yingshanhong tablets, compound RDF syrup, XiaoKeChuan syrup, and various traditional Chinese medicinal concoctions, and it holds significant importance in clinical settings.

2. Traditional and Historical Use

Antiquity and First Written Records

The first written reference to the species dates as far back as 401 B.C. This reference records the toxicity of rhododendron honey. Despite their toxicity, rhododendrons have been used in ancient medical systems such as traditional Chinese and Ayurvedic medicine and also in European and North American folk medicine.

Traditional Chinese Medicine

In China, approximately 25 species of Rhododendron are used as traditional medicines or folk remedies to treat various diseases, of which R. molle (NaoYangHua) has the longest medicinal use history and has been documented in the Chinese Pharmacopoeia 2020 Edition for the treatment of rheumatic arthralgia and pain. The medicinal records of R. molle can be traced back to the Han Dynasty. The ancient Chinese medical book Shennong's Herbal Classic (Shennong Ben Cao Jing) recorded R. molle.

In China, many Rhododendron plants are used as traditional Chinese medicine or ethnic medicine for the treatment of respiratory diseases, pain, bleeding, and inflammation. The dried leaves of R. dauricum, generally known as "Man Shan Hong," have been traditionally applied as folk medicines to treat fever, copious phlegm, asthma, acute and chronic bronchitis, sore throat, dysentery, diabetes mellitus, cancer, and hypertension.

Ayurvedic and Himalayan Traditions

The ethnopharmacological relevance of rhododendrons corresponds to their geographical distribution, most species being used in traditional Chinese and Tibetan medicine, Nepalese herbalism, and the Ayurvedic medical system, with only a few in North American and European folk medicine. Rhododendron has been used extensively in Ayurveda, Traditional Chinese Medicine, and Tibetan Medicine, with practitioners using various parts of the plant to cure many ailments.

Phenolic acids obtained from its leaves and twigs have been reported to have anti-HIV, anti-inflammatory, and anti-nociceptive activities, and its leaves and flowers are also utilized for treating illness, headache, diabetes, and rheumatism in the Himalayan tradition. In Nepal, the flower is considered edible and consumed for its sour taste; the pickled flower can last for months, and the flower juice is also marketed.

R. arboreum is used in folklore medicine to treat many disorders and is often used as a substitute for another famous plant drug Rohitaka. Pharmaceutical companies and traditional practitioners of Nepal use its bark as a substitute for Rohitaka, i.e., Tecomella undulata.

European and North American Folk Medicine

Rhododendron tomentosum Harmaja (previously Ledum palustre) is a fragrant evergreen shrub found in peaty soils in northern Europe, Asia, and North America. At least since the eighteenth century, it has been used in ethnomedicine for the treatment of various ailments such as rheumatism, cough, cold, and insect bites, as well as a repellent. In the nineteenth century, grayanotoxin/mad honey poisoning was reported in Europe and North America, indicating that the genus was also known to European practitioners who encountered its toxic potential.

Cross-Cultural Common Indications

Regardless of their distribution, most traditional indications are against inflammation, pain, common cold symptoms, skin ailments, and gastrointestinal disorders. Some members of the genus were used in traditional medicine for arthritis, acute and chronic bronchitis, asthma, pain, inflammation, rheumatism, hypertension, and metabolic diseases.

3. Key Constituents and Active Compounds

The genus is chemically prolific. In the past 13 years alone, a total of 610 chemical constituents were reported in Rhododendron plants, including 222 diterpenoids, 122 triterpenoids, 103 meroterpenoids, 71 flavonoids, 21 lignans, 22 phenolic acids, 25 sesquiterpenoids, 8 monoterpenoids, 11 coumarins, and 4 minor components. Rhododendron is known for its abundant metabolites, especially diterpenoids.

Flavonoids

Among all compound classes, flavonoids are considered characteristic components and major bioactive phytochemicals. Species-specific flavonoids identified across the genus include hyperoside (hyperin), avicularin, quercetin, kaempferol, astilbin, taxifolin, catechin, myricetin 3-O-galactoside, quercitrin, and guaijaverin. Based on research on the Rhododendron genus, nine compounds have been identified in negative ion mode, including catechin, myricetin 3-O-galactoside, hyperoside, avicularin, paeoniflorin, astragalin, azaleatin, quercetin, and kaempferol. Hyperoside is one of the most abundant individual compounds; in R. przewalskii, it had a yield of 6.03 mg/g fresh material.

In R. dauricum foliage (RDF), chemical elements are predominantly flavonoids, volatile oils, phenols, coumarin, and lignans.

Diterpenoids — Grayanotoxins

Grayanotoxins (GTXs) are naturally occurring toxins with diterpenoid structures, predominantly found in species of Rhododendron, and are responsible for food poisoning associated with honey, commonly referred to as mad honey. More than 25 grayanotoxin isoforms have been identified from Rhododendron species, but grayanotoxin I and III are thought to be the principal toxic isoforms. Different Rhododendron species contain multiple different grayanotoxin isoforms, contributing to differences in plant toxicity.

Grayanotoxin, also known as rhodotoxin, can be found in the leaves, twigs, flowers, and secondary products of plants belonging to the Ericaceae family. Not all species contain grayanotoxins in comparable concentrations; the levels vary substantially by species and plant part.

Meroterpenoids

Daurichromenic acid (DCA), a constituent of Rhododendron dauricum, is a meroterpenoid with antibacterial, anti-HIV, and anti-inflammatory activities. Although DCA exhibits these activities, the mechanisms underlying its pharmacological effects are poorly understood.

Triterpenoids

Re-extraction of R. luteum leaf material with the addition of a polar co-solvent resulted in the release of significant amounts of triterpene acids, particularly oleanolic and ursolic acids (145.33 ± 5.86 mg/g dry extract). These secondary metabolites present multiple pharmacological effects: among others, they have anticancer, antidiabetic, anti-infectious, lipidemic, cardioprotective, antiosteoporotic, anti-inflammatory, and neuroprotective properties, and both compounds are considered non-toxic and are used as ingredients in dietary supplements.

Arylbutanoid Glycosides — Rhododendrin

Four compounds have been isolated from the active fraction of R. aureum leaves and identified as (–)-rhododendrol, (–)-rhododendrin, avicularin, and hyperoside by spectroscopic methods. Rhododendrin, the main compound of the butanol fraction, exhibited significant analgesic actions in mice and anti-inflammatory actions in rats; this compound accounted for 3.1% of the methanol extract and 0.48% of dried leaves on HPLC analysis, suggesting it is a major biologically active substance in the leaves of R. aureum.

Other Phytochemical Classes

Rhododendron arboreum contains flavonoids, alkaloids, terpenoids, glycosides, steroids, anthraquinones, saponins, and tannins. Rhododendron spp. are well-known repositories of various bioactive secondary metabolites such as steroids, alkaloids, flavonoids, glycosides, saponins, tannins, etc., which are responsible for its medicinal virtues.

4. Mechanisms of Action

Grayanotoxins: Sodium Channel Modulation

The toxicity of grayanotoxin is derived from its ability to interfere with voltage-gated sodium channels located in the cell membrane of neurons. More specifically, the toxicity of grayanotoxin lies in its ability to bind to the group II receptor site in voltage-gated sodium channels (Na_v1.x) within the cell. Consumption of grayanotoxin-containing leaves, flowers, or secondary products such as honey may result in intoxication specifically characterized by dizziness, hypotension, and atrial-ventricular block; symptoms are caused by an inability to inactivate neural sodium ion channels, resulting in continuous increased vagal tone.

Flavonoids: Antioxidant and Anti-inflammatory Mechanisms

The antioxidant activity of Rhododendron extracts is primarily attributed to their flavonoid content. Extracts of R. przewalskii presented promising anti-inflammatory and antioxidant activities, containing valuable flavonoids (8.98 mg/g fresh material) that are likely the active compounds contributing to the potential antioxidant activity.

Daurichromenic Acid: Enzyme Inhibition

DCA inhibits the activity of the enzyme sphingomyelin synthase, with an IC₅₀ of 4 µM; the structure–activity relationships between DCA and sphingomyelin synthase were evaluated using derivatives, and DCA was also found to inhibit amyloid β aggregation. These findings are preclinical in nature and of preliminary significance only.

Analgesic/Anti-nociceptive Mechanisms

Rhodojaponin VI (RJ-VI) has considerable anti-nociceptive activity, particularly in inflammatory pain (at 0.3 mg/kg in animal models) and peripheral neuropathic pain (0.6 mg/kg); its toxicity was about three times lower than that of rhodojaponin III, and it mildly inhibits several subtypes of voltage-gated sodium channels (IC₅₀ >200 µM) that are associated with pain or cardiotoxicity.

5. Scientific Evidence by Area of Use

5.1 Respiratory Health (Antitussive and Expectorant Activity)

Traditional background and pharmacopoeial status: Rhododendron dauricum L. (Ericaceae) is a folk medicine used in China as an expectorant and mucolytic in the treatment of acute and chronic bronchitis. RDF functions as a cough and expectorant agent, primarily employed in the management of acute and chronic bronchitis and pharyngitis; it is also known for its pharmacological properties, including antibacterial, cardiotonic, antihypertensive, and anticancer properties.

Pharmacological evidence: The extracts and chemical components of LRD were found to show various pharmacological activities; LRD was commonly utilized to relieve cough and remove sputum and to treat tracheitis, with chemical components showing antitussive and expectorant effects. Clinically, R. dauricum is utilized for the treatment of asthma and thick phlegm resulting from bronchitis, demonstrating remarkable efficacy according to traditional clinical reports.

Evidence strength: Clinical data for the respiratory uses of R. dauricum predominantly derives from traditional Chinese medical practice and pharmacopoeial inclusion rather than controlled clinical trials published in the international peer-reviewed literature. Sufficient active components determination, in vivo and clinical pharmacological evaluation, toxicology assessment, and quality control of LRD all require further study. The evidence for antitussive/expectorant use is therefore classed as preliminary-to-moderate, supported by pharmacopoeial recognition and preclinical data but lacking robust randomized controlled trials.

5.2 Anti-inflammatory and Analgesic Activity

Cross-species pharmacological evidence: Rhododendrons have been used in Asian, North American, and European traditional medicine mainly against inflammation and pain. In vivo and in vitro testing of plant extracts and isolated compounds determined diverse biological activities including anti-inflammatory, analgesic, anti-microbial, anti-diabetic, insecticidal, and cytotoxic activity.

Animal studies — R. arboreum: In animal experiments, the ethyl acetate fraction of methanolic extract of R. arboreum bark (200 mg/kg i.p.) showed the maximum analgesic effect (82%) in the acetic acid-induced writhing test, followed by crude extract and chloroform fraction (65.09% and 67.89%, respectively, at the same dose). In carrageenan-induced mouse paw oedema, the crude extract and its related fractions displayed anti-inflammatory activity in a dose-dependent manner (50–200 mg/kg i.p.) across all time courses.

Isolated compound evidence — Rhododendrin: Rhododendrin, the main compound of the BuOH fraction from R. aureum leaves, exhibited significant analgesic actions in mice and anti-inflammatory actions in rats.

R. molle — analgesic compound research: Rhododendri Mollis Flos, the dried flowers of R. molle G. Don, have the ability to relieve pain, dispel wind and dampness, and dissolve blood stasis, but they are highly poisonous. Processing modifies both activity and toxicity: after processing, especially in vinegar, R. molle Flos did not only maintain anti-nociception but also showed reduced toxicity, and the chemical composition corresponding to these effects changed significantly.

Review-level assessment: Pharmacological data has validated most indications of rhododendrons in ethnomedicine, and toxicology studies have confirmed the toxicity observed in traditional use. Ethnopharmacological data point to the therapeutic potential of the genus Rhododendron for the treatment of inflammatory conditions and pain, and research should focus on identification of active compounds and related mechanistic studies.

Evidence strength: Anti-inflammatory and analgesic activity is well-supported by multiple in vitro and animal model studies across numerous species. However, no published randomized controlled human clinical trials were identified in the reviewed literature, and the evidence base therefore remains preclinical in nature.

5.3 Antioxidant Activity

Studies of R. arboreum petals demonstrated significant accumulation of antioxidant compounds, with total phenolic content (TPC) levels and total flavonoid content (TFC) identified at various concentrations; DPPH radical scavenging activity was highest in ethanolic extracts at 96.33%, compared to ascorbic acid standard at 77.38%. These findings indicate that R. arboreum petals, rich in bioactive compounds, possess strong antioxidant and antibacterial properties, making them potential candidates for developing cost-effective therapeutic formulations.

Evidence strength: Antioxidant effects have been demonstrated robustly in vitro across many species and preparations; no human interventional trials have been identified in the reviewed sources.

5.4 Antimicrobial Activity

Antibacterial properties of R. arboreum petal extracts were significant against Aeromonas hydrophila, Staphylococcus aureus, and Escherichia coli at 100% concentration. Cytotoxicity profiling of Rhododendron leaf extracts used in antimicrobial research has also established that further experiments are required to identify the specific compounds in Rhododendron leaf extracts that exert antimicrobial activity while being non-cytotoxic when applied onto human skin or gastrointestinal tract mucosa, and that detailed phytochemical profiling and compound identification is needed to exploit these components as supplementary agents in antimicrobial phyto-medical treatments.

Evidence strength: Antimicrobial activity is established in vitro for multiple species and multiple pathogens. In vivo and clinical evidence is absent in the reviewed literature.

5.5 Anti-hyperuricemic Activity

The anti-hyperuricemic effect of active phytochemicals from R. oldhamii leaf extracts was investigated using potassium oxonate-induced acute hyperuricemia; six phytochemicals, including (2R,3R)-epicatechin, (2R,3R)-taxifolin, (2R,3R)-astilbin, hyposide, guaijaverin, and quercitrin, were isolated using the developed screening method. This work was conducted in animal models. Evidence strength: Animal model only; no human trials identified.

5.6 Anti-diabetic Activity

Recent scientific research has reported promising antidiabetic properties for R. tomentosum. Mad honey prepared from Rhododendron species provides traditional therapeutic benefits for hypertension and diabetes, though it also poses toxic risks due to the presence of grayanotoxins. The antidiabetic potential of several Rhododendron species identified in the Canadian boreal forest has also been investigated, though details of dose, species, and outcome specifics were not fully available in reviewed sources. Evidence strength: Preliminary, predominantly in vitro and animal data.

5.7 Hepatoprotective Activity

Research provides compelling evidence for the hepatoprotective and antioxidant properties of Rhododendron ferrugineum leaves, with extracts demonstrating significant protective effects against paracetamol-induced liver toxicity in rat models and antioxidative benefits. In animal experiments, paracetamol treatment led to elevated levels of liver marker enzymes and disorientation in histological observations which were significantly reversed by treatment with Rhododendron arboreum Sm., dependent on dosage forms.

Evidence strength: Hepatoprotection has been demonstrated in rat models for at least two species; no human clinical trials were identified.

5.8 Cardiovascular Associations

Rhododendri Daurici Folium (RDF) is also known for pharmacological properties including antibacterial, cardiotonic, antihypertensive, and anticancer properties. At a mechanistic level, grayanotoxins — while toxic at higher doses — have historically been used at low doses. Lower doses of rhododendron honey could have potentially therapeutic short-term antiarrhythmic and long-term cardiovascular benefits, though more research is definitely warranted in this area to throw light on the therapeutic and toxic dose-dependent properties. Evidence strength: Cardiovascular effects from grayanotoxin-containing preparations are pharmacologically understood but the therapeutic window is narrow and poorly defined in humans. No clinical trials establishing a safe therapeutic dose were identified.

5.9 Neuropharmacological / Neuroprotective Activity

DCA from R. dauricum was found to inhibit amyloid β aggregation in preclinical assays. Research on new terpenoids from R. dauricum branches and leaves has also identified neuroprotective activity in vitro. Evidence strength: Very preliminary; in vitro data only.

5.10 Anticancer Activity

The crude extracts and compounds from R. dauricum leaves have been reported to possess cytotoxic effects. Various pharmacological properties of Rhododendron spp. such as anti-inflammatory, antimicrobial, antiviral, antioxidative, anti-diabetic, anticancer, hepatoprotective, and cardioprotective effects have been previously reported. Evidence strength: Cytotoxic and antimutagenic activities have been demonstrated in cell-based systems; no clinical trials have been identified.

6. Body Systems and Health Areas

• Respiratory system: Antitussive, expectorant, bronchitis (especially R. dauricum)
• Musculoskeletal/inflammatory: Arthritis, rheumatism, pain management
• Cardiovascular system: Traditional use in hypertension; grayanotoxin cardiac effects
• Gastrointestinal system: Diarrhea, dysentery, digestive complaints
• Metabolic: Diabetes, hyperuricemia, gout
• Hepatic: Hepatoprotection against chemically induced liver injury
• Skin and infections: Antibacterial, antifungal applications
• Nervous system: Neuroprotective (preclinical only); toxic neurological effects from grayanotoxin overdose

7. Dosage Forms and Reported Dosages

Chinese Pharmacopoeia — R. dauricum foliage (aqueous decoction): Previous reports suggesting relatively low overall toxicity refer to traditional clinical use and specific preparations such as aqueous decoctions, with the Chinese Pharmacopoeia recommending an adult dosage of 25–50 g per day.

Animal model doses — R. arboreum bark: The methanolic extract of R. arboreum bark at doses of 50–200 mg/kg i.p. was used in anti-inflammatory and antinociceptive studies, with the ethyl acetate fraction at 200 mg/kg i.p. showing the maximum analgesic effect of 82% in the acetic acid-induced writhing test.

Animal model doses — Rhodojaponin VI from R. molle: RJ-VI had considerable anti-nociceptive activity, particularly in inflammatory pain at 0.3 mg/kg and peripheral neuropathic pain at 0.6 mg/kg in animal models.

Hepatoprotective study — R. arboreum bark (rat, Ayurvedic preparations): The hepatoprotective effect of Choorna (powder, 0.54 g/kg body weight) and Kwatha (decoction, 4.32 ml/kg body weight) of R. arboreum Sm. was investigated orally for 10 days alongside paracetamol-induced toxicity in rats.

Toxicological data — acute oral LD₅₀: The acute toxicity of R. dauricum varies considerably depending on the extraction solvent, with oral LD₅₀ values in mice of approximately 24 g/kg for 90% ethanol extracts and 75 g/kg for aqueous decoctions.

Clinical dosage for non-R. dauricum species: The appropriate dose of rusty-leaved rhododendron (R. ferrugineum) depends on several factors; at present there is not enough scientific information to determine an appropriate range of doses for rusty-leaved rhododendron.

8. Safety, Toxicity, and Drug Interactions

Grayanotoxin Toxicity — "Mad Honey Disease"

Grayanotoxin/mad honey poisoning is a little-known but well-studied cholinergic toxidrome resulting in incapacitating and, sometimes, life-threatening bradycardia, hypotension, and altered mental status. Grayanotoxin is a naturally occurring sodium channel toxin which enters the human food supply via honey made from the pollen and nectar of the plant family Ericaceae, of which Rhododendron is a genus.

Major clinical effects include burning of the mouth, perioral numbness and tingling, nausea, vomiting, diaphoresis, diarrhea, bradydysrhythmias, coma, altered mental state, and seizures. In over 90% of reported cases, significant hypotension (systolic blood pressure 70 mmHg) and bradycardia (pulse rate of 48 beats/minute) are present, while in about 70% of exposures, the poisoning leads to diaphoresis, dizziness, and altered mental status.

Complete heart blocks occur in a significant fraction of patients. Asystole has been reported. Treatment with saline infusion and atropine alone is almost always successful.

In various cases, 50 to 75 mL of contaminated honey have caused toxicity due to a particular grayanotoxin isoform in the nectar of selected Ericaceae plants. Honey poisoning occurred in 66 adults following ingestion of 5 to 20 g (mean 13.45 ± 5.39 g) of honey produced from Rhododendron ponticum.

Contamination of honey occurs mainly in the eastern Black Sea region of Turkey, where bees produce honey from nectar derived from Rhododendron ponticum and Rhododendron luteum. Since most of the local beekeepers produce honey at a small scale, the final products can be obtained from a small area or even a single beehive and contain a considerable concentration of grayanotoxin.

Grayanotoxin-containing products are currently sold online, which may pose an increasing risk.

Species- and Preparation-Dependent Toxicity

The symptoms of grayanotoxin intoxication are similar to those of mad honey intoxication after the consumption of leaves, roots, bark, and flowers of the plants of the Ericaceae family, mainly Rhododendron species. In humans, intoxication is rarely lethal, in contrast to cattle and pet poisoning cases.

The possibility that particular extraction methods, fractions, or constituents may produce developmental toxicity or cardiotoxicity cannot be excluded. Specifically for R. molle, whose flowers are listed in the Chinese Pharmacopoeia, these flowers have the ability to relieve pain but they are highly poisonous.

Cytotoxicity of Leaf Extracts

Extracts of 12 Rhododendron species with the highest antibacterial potencies were applied in different concentrations to monolayer cultures of human HaCaT epidermal keratinocytes and rat intestine epithelial cell line IEC6; intestinal epithelial cells and keratinocytes are considered to be among the first points of contact when drugs are administered orally or applied ectopically. Results from that study indicated differential cytotoxic profiles among species, with some (R. minus and R. racemosum) being safe at 50 µg/mL, while others were cytotoxic at tested concentrations.

Evidence Gaps and Precautionary Statements

Scientific evidence for the medicinal properties of grayanotoxin-containing preparations, such as honey or herbal preparations in use in folk medicine, is scarce, and such use may even be harmful.

Prolonged and high-dose intake of traditional formulations containing rhododendrons should be avoided until more in-depth toxicity studies become available.

Apart from honey, grayanotoxins might be present in other products prepared from rhododendron, including flower juice, wine, or boiled extracts of rhododendron.

Interactions

No formally peer-reviewed clinical pharmacokinetic drug–drug interaction studies specific to Rhododendron preparations were identified in the reviewed literature. The sodium channel-modulating activity of grayanotoxins, however, creates a plausible mechanistic basis for interactions with antiarrhythmic agents, agents that affect cardiac conduction, and medications affecting autonomic tone. The dose-response relationship of grayanotoxins in both animal and human systems has not been well established. Given the cardiovascular and neurological mechanisms of the principal toxic constituents, clinical vigilance is warranted when Rhododendron preparations are used alongside cardiovascular drugs or CNS-active agents.

9. Summary of Evidence Quality

Across the breadth of pharmacological research on the genus Rhododendron, several patterns emerge. Rhododendron species are useful traditional remedies for the treatment of inflammation, pain, skin ailments, common cold, and gastrointestinal disorders; in vivo and in vitro testing of plant extracts and isolated compounds has determined diverse biological activities including anti-inflammatory, analgesic, anti-microbial, anti-diabetic, insecticidal, and cytotoxic activity. However, the overwhelming majority of this evidence is preclinical — derived from in vitro assays or animal models. The clinical data that does exist is largely embedded within the Chinese Pharmacopoeia and traditional use reporting, particularly for R. dauricum in respiratory illness. Rigorous controlled human clinical trials remain sparse to absent for most indications and species. Several deficiencies remain, including active component determination, in vivo and clinical pharmacological evaluation, toxicology assessment, and quality control of key preparations.

References

• Wu et al. (2023). Traditional uses, phytochemistry, pharmacology, toxicology, and quality control of Rhododendron dauricum L. leaves: A comprehensive review. Journal of Ethnopharmacology. PubMed.
• Zhao et al. (2023). An updated review of the genus Rhododendron since 2010: Traditional uses, phytochemistry, and pharmacology. Phytochemistry. ScienceDirect.
• Popescu & Kopp (2013). The genus Rhododendron: An ethnopharmacological and toxicological review. Journal of Ethnopharmacology. ScienceDirect.
• Niu et al. (2021). Multiple Biological Activities of Rhododendron przewalskii Maxim. Extracts and UPLC-ESI-Q-TOF/MS Characterization of Their Phytochemical Composition. Frontiers in Pharmacology.
• Chen et al. (2015). Antioxidative phytochemicals from Rhododendron oldhamii Maxim. leaf extracts reduce serum uric acid levels in potassium oxonate-induced hyperuricemic mice. BMC Complementary and Alternative Medicine. PMC.
• Regmi et al. (2020). In-vitro antioxidant, antimutagenic and cancer cell growth inhibition activities of Rhododendron arboreum leaves and flowers. PMC.
• Jansen et al. (2012). Grayanotoxin Poisoning: 'Mad Honey Disease' and Beyond. Cardiovascular Toxicology. PMC.
• Gunduz et al. (2008). Clinical review of grayanotoxin/mad honey poisoning past and present. Clinical Toxicology.
• Yavuz et al. (2019). Cardiovascular, psychiatric, and neurological phenomena seen in mad honey disease: A clinical case report. Clinical Case Reports. PMC.
• Ali et al. (2022). Mad honey: uses, intoxicating/poisoning effects, diagnosis, and treatment. RSC Advances. PMC.
• Nisar et al. (2016). Antinociceptive and anti-inflammatory potential of Rhododendron arboreum bark. Toxicology and Industrial Health. PubMed.
• Yonemitsu et al. (2011). Rhododendrin, an analgesic/anti-inflammatory arylbutanoid glycoside, from the leaves of Rhododendron aureum. PubMed.
• Li et al. (2024). Evaluation of Rhododendri Mollis Flos and its representative component as a potential analgesic. PubMed.
• Choi et al. (2020). Daurichromenic Acid from the Chinese Traditional Medicinal Plant Rhododendron dauricum Inhibits Sphingomyelin Synthase and Aβ Aggregation. PMC.
• Gescher et al. (2015). Assessment of cytotoxicity exerted by leaf extracts from plants of the genus Rhododendron towards epidermal keratinocytes and intestine epithelial cells. BMC Complementary and Alternative Medicine. PMC.
• Biswas et al. (2019). Bioactive compounds, health benefits and utilization of Rhododendron: a comprehensive review. Agriculture & Food Security. Springer Nature.
• Regmi et al. (2024). In Vitro Antioxidant and Antibacterial Activities of Medicinal Flower Laligurans Rhododendron arboreum Collected from Kathmandu Valley, Nepal. PMC.
• Frontiers in Chemistry (2025). Chemical profile of Rhododendron luteum Sweet leaf supercritical CO₂ extracts and their anti-inflammatory and antidiabetic potential.
• Li et al. (2025). Rhododendri Daurici Folium: An Overview of Herbal Medicine, Chemical Composition, Pharmacological Action, Clinical Application, and Quality Control. Phytochemical Analysis. Wiley.
• Dampc & Luczkiewicz (2013). Rhododendron tomentosum (Ledum palustre): A review of traditional use based on current research. Fitoterapia. ScienceDirect.
• Pradhan et al. (2022). Antioxidant, antimicrobial and phytochemical analysis of three endemic Rhododendron spp. of Sikkim Himalaya. South African Journal of Botany. ScienceDirect.
• Parajuli et al. (2025). Bioactivity assessment of methanolic extract of Rhododendron cowanianum: An endemic species of Nepal. PMC.
• Popescu & Kopp (2013). The genus Rhododendron: An ethnopharmacological and toxicological review. Academia.edu.
• Tang & Eisenbrand (1992). Rhododendron dauricum L. In: Chinese Drugs of Plant Origin. Springer, Berlin, Heidelberg.
• Ncbi.nlm.nih.gov. PMC2300134. (2008). Related grayanotoxin clinical data. PMC.